News and Press Releases

Prosarix receives grant of patent US 8,222,254

Cambridge, UK, July 25th 2012 — Prosarix announces that it has been granted US Patent 8,222,254 as of 17th July 2012 relating to its novel serotonergic modulator program. This represents the second territory grant of this patent family.


©Prosarix 2007-2020

℅ RxCelerate Ltd, Moneta B280, Babraham Research Park, Cambridge, CB22 3AT ¦ +44 (0)1223 839557 ¦ ¦ legal